From Health Affairs. By Jerry Avorn, MD. SUMMARY: This Health Affairs editorial introduction by Dr. Avorn opens a thematic issue devoted to the relationship between prescription drugs and the elderly population. Avorn, identified as one of very few academically affiliated physicians specializing in this area, provides an overview of the issue's scope, which spans geriatric drug development, elderly participation in clinical trials, pharmaceutical pricing, drug utilization pat
